A message from Simon Smith CEO Covalon Technologies Europe.

30th September 2020

Shona MacDonald, UK and Ireland MD will be leaving Covalon from the 1st of October. We are sad to see Shona go but wish her the very best in her new role. Shona’s driving force has made a huge impact in both the establishment of Covalon on the UK market and driving the direction of the company to align with the principals for the Future operating Model of the NHS.
Covalon’s principals of changing the status quo in wound care continues and we carry on bringing cost savings and quality to the NHS and other customers. Shona prepared the following statement.

“It is with mixed emotions that I am moving on from my position at Covalon Technologies Ltd.  The Covid-19 pandemic offered an extreme opportunity to reassess my career path. I remain eternally grateful to Covalon who supported my part time return to front line clinical practice and to follow my passions. I now move full time into an NHS strategic role and will continue to support our NHS from within. It has been my honour to have been instrumental in the successful launch of the company into the UK market, and wish Covalon every success with this venture on this next phase of their growth journey.”


This website is intended for healthcare professionals. If you are a patient who has been prescribed CovaWound™, whilst we hope you find the website interesting, please remember that your clinical team should be your primary point of contact for any queries related to your wound care.

Our Privacy Policy
Contact Us

Covalon Technologies (Europe) Ltd, No 1 Mill, The Wharf, Shardlow, Derbyshire, DE72 2GH

T: +44 (0) 1332 322469


© 2021 Covalon Technologies (Europe) Ltd
CovaWound is a trademark of Covalon Technologies Ltd.

Designed by Burnt Orange Creative